Cancer progression and tumor hypercoagulability: a platelet perspective
- 17 May 2024
- journal article
- review article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 57 (6) , 959-972
Abstract
Venous thromboembolism, which is common in cancer patients and accompanies or even precedes malignant tumors, is known as cancer-related thrombosis and is an important cause of cancer- associated death. At present, the exact etiology of the elevated incidence of venous thrombosis in cancer patients remains elusive. Platelets play a crucial role in blood coagulation, which is intimately linked to the development of arterial thrombosis. Additionally, platelets contribute to tumor progression and facilitate immune evasion by tumors. Tumor cells can interact with the coagulation system through various mechanisms, such as producing hemostatic proteins, activating platelets, and directly adhering to normal cells. The relationship between platelets and malignant tumors is also significant. In this review article, we will explore these connections.Keywords
Funding Information
- National Natural Science Foundation of China (82172776)
- Tianjin Science and Technology Plan Project (19ZXDBSY00060)
This publication has 179 references indexed in Scilit:
- Efficiently Restored Thrombopoietin Production by Ashwell‐Morell Receptor and IL‐6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial HepatectomyHepatology, 2020
- Managing thrombosis in cancer patientsResearch and Practice in Thrombosis and Haemostasis, 2018
- Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment studyAmerican Journal of Hematology, 2015
- Inhibition of platelet activation prevents the P‐selectin and integrin‐dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivoInternational Journal of Cancer, 2014
- Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patientsCancer, 2009
- Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational studyCancer, 2005
- Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinomaCancer, 2002
- Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinomaCancer, 2001
- Differing platelet aggregating effects by two tumor cell lines: Absence of role for platelet‐derived ADPAmerican Journal of Hematology, 1981
- Thrombocytosis Associated With Malignant DiseaseArchives of internal medicine (1960), 1964